本期内容提示:
1、美股大盘跌跌不休,是否有抄底机会?$纳指100ETF-Invesco(QQQ)$
2、$Solid Biosciences(SLDB)、$Valneva SE(VALN)增发,是否有机会跟仓?
3、$贝壳(BEKE)$ 、$创新ETF-ARK(ARKK)$ 、$Twitter(TWTR)、$中概互联网指数ETF-KraneShares...查看全文
不入流资讯11-15 09:50
$Solid Biosciences(SLDB)$ Solid Biosciences +38% as FDA clears IND for muscular dystrophy therapy查看全文
Solid Biosciences(SLDB)11-15 21:35
$Solid Biosciences(SLDB)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-23-277552 Act: 34 Size: 176 KB 网页链接查看全文
Solid Biosciences(SLDB)10-21 04:25
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-054388 Size: 7 KB 网页链接查看全文
Solid Biosciences(SLDB)10-21 04:25
$Solid Biosciences(SLDB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-23-054381 Size: 15 KB 网页链接查看全文
Solid Biosciences(SLDB)10-06 03:15
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-052171 Size: 7 KB 网页链接查看全文
Solid Biosciences(SLDB)09-07 04:45
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-046760 Size: 9 KB 网页链接查看全文
美股滚雪球01-12 12:19
$Solid Biosciences(SLDB)$ 和Phlox Therapeutics达成战略合作,开发针对遗传性心脏病的精准药物。这项研究合作将针对一种严重的遗传性扩张型心肌病(DCM)。
这项战略合作将整合Solid的载体生物学、制造能力和药物开发经验,以及Phlox在遗传心肌病和RNA治疗方面的专业知识。
两家公司表示,...查看全文
牛唐2022-10-03 15:50
医药板块速评(2022.09.30)
本期内容提示:
1、美股大盘跌跌不休,是否有抄底机会?$纳指100ETF-Invesco(QQQ)$
2、$Solid Biosciences(SLDB)、$Valneva SE(VALN)增发,是否有机会跟仓?
3、$贝壳(BEKE)$ 、$创新ETF-ARK(ARKK)$ 、$Twitter(TWTR)、$中概互联网指数ETF-KraneShares...查看全文
美股滚雪球2022-10-02 22:24
$Solid Biosciences(SLDB)$ 宣布收购基因治疗公司AavantiBio,旨在推进一系列神经肌肉和心脏项目,预计四季度完成合并。
交易完成后,AavantiBio现任首席执行官Bo Cumbo将担任Solid Biosciences的总裁兼首席执行官。
为支持此次收购,SLDB已与一些选定的机构投资者和合格投资者达成了一项...查看全文
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-063216 Size: 5 KB 网页链接
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-063218 Size: 4 KB 网页链接
$Solid Biosciences(SLDB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-033569 Size: 5 KB 网页链接
$Solid Biosciences(SLDB)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-20-315926 Act: 34 Size: 38 KB 网页链接
$Solid Biosciences(SLDB)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001193125-20-315381 Act: 34 Size: 511 KB 网页链接
$Solid Biosciences(SLDB)$ 8-K Current report, item 5.02 Accession Number: 0001193125-20-298702 Act: 34 Size: 151 KB 网页链接
$Solid Biosciences(SLDB)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001193125-20-287986 Act: 34 Size: 49 KB 网页链接
$Solid Biosciences(SLDB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-20-050874 Act: 34 Size: 8 MB 网页链接
$Solid Biosciences(SLDB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-20-286209 Act: 34 Size: 235 KB 网页链接
$Solid Biosciences(SLDB)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-20-000595 Act: 34 Size: 46 KB 网页链接